Aurinia Pharmaceuticals (AUPH) Misses Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Aurinia Pharmaceuticals (AUPH) Misses Q2 EPS by 4c

Aurinia Pharmaceuticals (AUPH) PT Raised to $15 at H.C. Wainwright

August 13, 2018 7:19 AM EDT

H.C. Wainwright analyst Ed Arce raised the price target on Aurinia Pharmaceuticals (NASDAQ: AUPH) to $15.00 (from $12.00) while maintaining a Buy rating.

Arce comments "Under voclosporin's Fast Track designation,Aurinia is actively preparing the rolling NDA submission, with the first... More